Real needle-free GLP-1 exists: the Wegovy oral tablet (oral semaglutide 25 mg, FDA-approved December 2025, 13.6% weight loss in the OASIS 4 trial) and experimental microneedle patches from Daewoong Therapeutics (80% bioavailability in a 70-person Phase 1 study, 2028-2030 market estimate)
If a pheochromocytoma coexists, it should be treated with alpha-blocker and removed by laparoscopic or retroperitoneal adrenalectomy before thyroid surgery to prevent hypertensive crisis [1,4,6]
Therefore, it is especially important to consider the scale of misery for individuals as well as nations (403)
If an off-label Ozempic prescription has been suggested elsewhere for weight loss, consider switching to a medication with precise FDA guidance for this use
Based on these studies, the FDA approved Wegovy injections for chronic weight management ONLY in adults with a BMI over 30 or over 27 with at least one weight-related condition (high blood pressure, type 2 diabetes, or high cholesterol)
It is recommended to discuss with a healthcare aid to discuss the potential benefits and risks of Ozempic for weight loss, as well as to determine the right treatment plan based on your individual needs and past medical history
